Compare INSG & ALPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | INSG | ALPS |
|---|---|---|
| Founded | 1996 | 2017 |
| Country | United States | Malaysia |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2M | 66.6M |
| IPO Year | 2000 | 2024 |
| Metric | INSG | ALPS |
|---|---|---|
| Price | $4.33 | $0.36 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.67 | N/A |
| AVG Volume (30 Days) | ★ 331.9K | 49.2K |
| Earning Date | 11-05-2026 | 07-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $313,832,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.21 | N/A |
| P/E Ratio | $35.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.58 | $0.23 |
| 52 Week High | $21.90 | $1.72 |
| Indicator | INSG | ALPS |
|---|---|---|
| Relative Strength Index (RSI) | 47.44 | 38.51 |
| Support Level | $3.96 | $0.23 |
| Resistance Level | $4.61 | $0.44 |
| Average True Range (ATR) | 0.27 | 0.02 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 57.10 | 29.57 |
Inseego Corp is involved in the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things, and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by application software and cloud services designed to enable customers to analyze data insights and configure and manage their hardware easily. It generates maximum revenue from the United States and Canada. The company also has a presence in Europe (including the United Kingdom).
ALPS Group Inc is an investment holding company involved in research and development, including stem cell and biotechnology-related business, and investing and managing businesses such as health and beauty centres and medical centres. The Company operates through Medical and Wellness, Life Science and Others segments. Medical and Wellness generates maximum revenue from non-surgical aesthetic services, surgical aesthetic services, medical consultation, health screenings, cellular therapy and research, and COVID-19 testing. Life Science provides whole-genome sequencing and pharmacogenomics, while Others comprises investment holding and provision of management services. The Company generates revenue in Malaysia.